FDA Approves Dupixent for Prurigo Nodularis
This priority review-based approval makes Dupixent the first treatment for the inflammatory skin condition
Sign in to PracticeUpdate
Only registered members have full access to PracticeUpdate content.
This priority review-based approval makes Dupixent the first treatment for the inflammatory skin condition
Only registered members have full access to PracticeUpdate content.